RecallRadar
FDA · DrugsClass I

Shoppers- Plaza drug recall: FOUZEE SugarLin HERBAL FORMULA capsules

Undeclared allergens

Key facts

Agency
U.S. Food and Drug Administration (FDA)
Program
Drugs
Classification
Class I
Status
Ongoing
Event ID
95994
Recall initiated
Dec 16, 2024
Classified by FDA
Jan 22, 2025
Posted in Enforcement Report
Jan 29, 2025
Recalling firm
SHOPPERS- PLAZA
Firm location
Hawthorne, CA, United States
Initiated by
Voluntary: Firm initiated
Firm notified customers by
Press Release
Products in this event
1

What to do

Compare the product, lot or serial numbers below with what you have. If you use a prescription drug or medical device in this recall, talk to your pharmacist or health care provider before you stop using it, and follow the firm's instructions.

View the official FDA record ↗

Reason for recall

Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide

What the classification means

  • Class I: FDA's most serious category: there is a reasonable probability that using or being exposed to the product will cause serious health problems or death.

About this recall

The firm started this recall on Dec 16, 2024. FDA classified it 37 days later, on Jan 22, 2025. Distribution reported by FDA: Nationwide via internet sales

Recalled products (1)

  • D-0207-2025 Class I Ongoing

    FOUZEE SugarLin HERBAL FORMULA capsules, 180 capsules per bottle, Sold and Distributed by Shoppers-Plaza, Hawthorne, CA 90250. Product of India. UPC 8 26656 69047 7

    Codes / lots: Batch # 001, exp. date 09/10/2026

    Quantity: 172 180-count bottles

Source and freshness

Source
U.S. Food and Drug Administration (FDA) Enforcement Report, via the openFDA drug enforcement dataset
Official notice
FDA Enforcement Report, event 95994
Raw record
openFDA API (JSON)
Dataset last updated by FDA
Nov 3, 2026
Imported by RecallRadar
Nov 4, 2026

Enforcement Report entries describe recalls FDA has classified. They are not always the same as a company press release. If something here differs from FDA's record, FDA's record is correct — please tell us.